870 results
8-K
EX-99.2
MRK
Merck & Co Inc
19 Feb 13
Results of Operations and Financial Condition
12:00am
)
Research and development (1)
Restructuring costs (2)
Equity income from affiliates (3)
Other (income) expense, net (1)(4)
Income Before Taxes
Income Tax … Assuming Dilution (5)
Average Shares Outstanding Assuming Dilution
Tax Rate (6)
* 100% or greater
(1) Amounts include the impact of acquisition-related
8-K
EX-99.1
q8jppswc2og2ekn
29 Oct 19
Merck Announces Third-Quarter 2019 Financial Results
6:50am
S-3ASR
75gvt167fayumqaks
2 Aug 07
Automatic shelf registration
12:00am
424B2
f36t i26one
10 Aug 07
Prospectus for primary offering
12:00am
8-K
EX-99.2
g5hk6zeq uar
5 Feb 20
Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results
6:50am
8-K
EX-99.1
kmd4cad
30 Jul 19
Merck Announces Second-Quarter 2019 Financial Results
6:50am
424B5
5re5s50xag9f vgj5
8 May 23
Prospectus supplement for primary offering
8:17am
424B5
607n75w 60qat
7 Dec 21
Prospectus supplement for primary offering
8:13am
424B5
ttgk1b
10 Sep 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
yxs2o3vog yh
5 Feb 20
Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results
6:50am
CORRESP
z7y5y533ab 5es
3 Aug 12
Correspondence with SEC
12:00am